Drug Shortage Report for PMS-IRBESARTAN-HCTZ
| Report ID | 218776 |
| Drug Identification Number | 02328534 |
| Brand name | PMS-IRBESARTAN-HCTZ |
| Common or Proper name | IRBESARTAN-HCTZ |
| Company Name | PHARMASCIENCE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROCHLOROTHIAZIDE IRBESARTAN |
| Strength(s) | 25MG 300MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | C09DA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-02-02 |
| Estimated end date | 2024-05-27 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-04-12 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2024-04-12 | French | Compare |
| v5 | 2024-04-12 | English | Compare |
| v4 | 2024-02-28 | French | Compare |
| v3 | 2024-02-28 | English | Compare |
| v2 | 2024-02-07 | French | Compare |
| v1 | 2024-02-07 | English | Compare |
Showing 1 to 6 of 6